Your English writing platform
Discover LudwigSuggestions(1)
Exact(60)
Recently we completed a large market study for patients and healthcare specialists to better understand their needs and ensure our product marries up the benefits for both parties.
The most important message from the study for patients is, "if you are told you need a mastectomy, ask why," Dr. Morrow said.
This is a phase II study for patients with squamous cell carcinoma of the head and neck who have residual disease following definitive therapy with radiation (with or without systemic therapy).
Triapine 105 mg/m2 followed by fludarabine 30 mg/m2 daily × 5 is active in refractory myeloid malignancies and warrants continuing study for patients with aggressive MPD.
Due to the lack of specific serological markers for the diagnosis of immune-mediated hearing loss, an exhaustive immunologic work-up study for patients is usually performed.
The activity and toxicity of topotecan were evaluated in a multicenter Phase II study for patients with previously treated squamous cell carcinoma of the uterine cervix.
Furthermore, some follow-ups were not available in our study for patients sent to our center only for tubal assessments by their gynaecologists or family doctors.
The results to date tend to support the conclusions drawn from the retrospective study for patients with the more poorly differentiated types (WHO 2 and WHO 3) of this disease.
The study was designed as a prospective cohort study for patients admitted to the nine intensive care units in the four provincial academic medical centers from September 2013 to February 2014.
In the present study, for patients with RVR, SVR was achieved in 79.0% of the instances, significantly higher than patients without RVR (SVR: 44.83%, P <0.001).
False alarm rates in recognition (proportion of foil items that is falsely recognized) were about 50% higher in the Elvevåg study for patients than for healthy controls (0.12 vs. 0.19, computed on the basis of their Table 3).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com